DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

GILEAD.
Gilead Announces Topline Data From Phase 3 STELLAR-3 Study of Selonsertib in Bridging Fibrosis (F3) Due to Nonalcoholic Steatohepatitis (NASH).
2019

Download Bibliographical Data

Search in: